Integrase strand transfer inhibitors

DRUG2 trials

Sponsors

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Conditions

HIV Infections

Phase 4

Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide

CompletedNCT04636437

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsHIV Infections

Start: 2021-07-27End: 2024-10-18Updated: 2025-07-02

Unknown Phase

ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome

CompletedNCT04460924

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalHIV Infections

Start: 2020-11-01End: 2023-03-01Updated: 2023-09-13

Related Papers

A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).

2026-03-18

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor–Based Regimen Switch Strategy to Manage Integrase Inhibitor–Related Weight Gain

Clinical Infectious Diseases2024-09-049 citations